Skip to content
Screener

Amneal Pharmaceuticals, Inc. AMRX Proceeds from disposals of property, plant and equipment

Proceeds from disposals of property, plant and equipment at other companies

Cardinal Health, Inc. logo
Cardinal Health, Inc.CAH
$7.75M
Emergent Biosolutions logo
Emergent BiosolutionsEBS
$200K+100%

Other financials

Income statement

See full
Revenue$796.2M+9.9%
Gross profit$334.5M+16.9%
Operating income$129.8M+16.5%
Net income$57.7M+157%
EPS (diluted)$0.18+157%

Balance sheet

See full
Cash & equivalents$127.6M+78.4%
Total debt$2.6B+18.0%
Total equity$33.0M+129%
Total assets$3.8B+10.3%

Cash flow

See full
Operating cash flow-$21.2M-125%
CapEx$30.7M+34.5%
Free cash flow-$51.9M-185%

Valuation

See full
Market cap$5.71B+113%
Enterprise value$8.15B+70.5%
P/E36.3×-757×
P/S1.8×+0.9×

Profitability

See full
Gross margin39.3%+1.7pp
Operating margin14.6%+1.4pp
Net margin5%+4.9pp
FCF margin4.1%-5.8pp

Returns & leverage

See full
Return on equity-52.8%-12.7pp
Debt / equity77.8×
Current ratio2.2×+0.8×

Where this comes from

Reported directly by Amneal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.

The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001723128-26-000031
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Purchases of property, plant and equipment(38,872)(35,992)
Acquisition of intangible assets(85,000)(5,100)
Deposits for future acquisition of property, plant and equipment(20,580)(4,632)
Proceeds from sale of property, plant and equipment1,379
Net cash used in investing activities(144,452)(44,345)
Cash flows from financing activities:
Payments of principal on debt, revolving credit facilities, financing leases and other(147,027)(251,076)
Proceeds from issuance of debt134,673

Item 1. Financial Statements (Unaudited)

FAQ

What is Amneal Pharmaceuticals, Inc.'s proceeds from disposals of property, plant and equipment?
Amneal Pharmaceuticals, Inc. (AMRX) reported proceeds from disposals of property, plant and equipment of $0 in Q2 2026.
How has Amneal Pharmaceuticals, Inc.'s proceeds from disposals of property, plant and equipment changed year-over-year?
Amneal Pharmaceuticals, Inc.'s proceeds from disposals of property, plant and equipment decreased by 100.0% year-over-year, from $855K to $0.
What does proceeds from disposals of property, plant and equipment mean?
Proceeds from disposals of property, plant and equipment

Ask your AI about Amneal Pharmaceuticals, Inc.'s proceeds from disposals of property, plant and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude